Organization · Private Equity
ARCHIMED
ARCHIMED is a global private equity investment firm based in Lyon, France, specializing in the healthcare sector. With a focus on profitable small and mid-sized companies, it leverages a diverse team to drive growth and innovation in healthcare.
Overview
What ARCHIMED does
What ARCHIMED is
ARCHIMED is a global private equity investment firm based in Lyon, France, specializing in the healthcare sector. With a focus on profitable small and mid-sized companies, it leverages a diverse team to drive growth and innovation in healthcare.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 3, 2026
Official channels
Find ARCHIMED elsewhere
Open the official website or a supported primary organization account.
Capability profile
ARCHIMED as a funder
Investment thesis
ARCHIMED invests in profitable small and mid-sized companies within the healthcare sector, targeting growth through innovation, internationalization, acquisitions, and capacity expansion.
Focus narrative
ARCHIMED invests in profitable small and mid-sized companies within the healthcare sector, with investments ranging from €10 million to €1 billion. The firm targets eight prioritized healthcare sectors, including Biopharma Products, Consumer Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, Pharma Services, and Animal & Environmental Health. ARCHIMED's investment strategy emphasizes growth through innovation, internationalization, acquisitions, and capacity expansion.
Terms and economics
- Typical check
- $10,000,000–$1,000,000,000
Focus and fit
- Regions
- Asia · Europe · Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Citieffe
Portfolio context
Notable portfolio companies include: Suanfarma: A leader in the active pharmaceutical ingredient market, which has transitioned its subsidiary SuanNutra into a standalone business. Citieffe: An orthopedic implants maker sold to Poly Medicure, marking the last investment in ARCHIMED’s MED I fund. ARK Diagnostics: A global leader in disease and drug monitoring and detection, recently acquired by ARCHIMED Diagnostics.
Common questions
What to know about ARCHIMED
Upseed classifies ARCHIMED under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.